BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22617845)

  • 1. Low-fidelity Venezuelan equine encephalitis virus polymerase mutants to improve live-attenuated vaccine safety and efficacy.
    Kautz TF; Guerbois M; Khanipov K; Patterson EI; Langsjoen RM; Yun R; Warmbrod KL; Fofanov Y; Weaver SC; Forrester NL
    Virus Evol; 2018 Jan; 4(1):vey004. PubMed ID: 29593882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA helicase DDX39A binds a conserved structure in chikungunya virus RNA to control infection.
    Tapescu I; Taschuk F; Pokharel SM; Zginnyk O; Ferretti M; Bailer PF; Whig K; Madden EA; Heise MT; Schultz DC; Cherry S
    Mol Cell; 2023 Nov; 83(22):4174-4189.e7. PubMed ID: 37949067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine development for zoonotic viral diseases caused by positive‑sense single‑stranded RNA viruses belonging to the
    Babaeimarzangou SS; Zaker H; Soleimannezhadbari E; Gamchi NS; Kazeminia M; Tarighi S; Seyedian H; Tsatsakis A; Spandidos DA; Margina D
    Exp Ther Med; 2023 Jan; 25(1):42. PubMed ID: 36569444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action.
    Maruggi G; Ulmer JB; Rappuoli R; Yu D
    Curr Top Microbiol Immunol; 2022; 440():31-70. PubMed ID: 33861374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.
    Monette A; Mouland AJ
    Int Rev Cell Mol Biol; 2019; 342():175-263. PubMed ID: 30635091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1.
    Baer A; Lundberg L; Swales D; Waybright N; Pinkham C; Dinman JD; Jacobs JL; Kehn-Hall K
    J Virol; 2016 Jan; 90(7):3558-72. PubMed ID: 26792742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Nanotrap particles for biodefense and emerging infectious disease diagnostics.
    Shafagati N; Patanarut A; Luchini A; Lundberg L; Bailey C; Petricoin E; Liotta L; Narayanan A; Lepene B; Kehn-Hall K
    Pathog Dis; 2014 Jul; 71(2):164-76. PubMed ID: 24449537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic hypo- or non-responder in natural dengue virus infection.
    Perng GC; Chokephaibulkit K
    J Biomed Sci; 2013 May; 20(1):34. PubMed ID: 23725050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.
    Tretyakova I; Lukashevich IS; Glass P; Wang E; Weaver S; Pushko P
    Vaccine; 2013 Feb; 31(7):1019-25. PubMed ID: 23287629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.
    Dupuy LC; Richards MJ; Ellefsen B; Chau L; Luxembourg A; Hannaman D; Livingston BD; Schmaljohn CS
    Clin Vaccine Immunol; 2011 May; 18(5):707-16. PubMed ID: 21450977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
    Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.
    Sharma A; Knollmann-Ritschel B
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30781656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The vaccines based on the replicon of the venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers].
    Petrov AA; Plekhanova TM; Sidorova ON; Borisevich SV; Makhlay AA
    Vopr Virusol; 2015; 60(3):14-8. PubMed ID: 26281301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83): comparison of naïve, vaccine responder and nonresponder to TC-83 challenge in human peripheral blood mononuclear cells.
    Erwin-Cohen R; Porter A; Pittman P; Rossi C; Dasilva L
    Hum Vaccin Immunother; 2012 Aug; 8(8):1053-65. PubMed ID: 22617845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood.
    Erwin-Cohen RA; Porter AI; Pittman PR; Rossi CA; DaSilva L
    Hum Vaccin Immunother; 2017 Jan; 13(1):169-179. PubMed ID: 27870591
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.